Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF inhibitor bevacizumab to be cleared for use by the NHS in England and Wales for treating wet age-related macular ...

Tired of feeling like you’re overwearing your contacts by the end of the day and are stuck dealing with dry, irritated eyes? Maybe it’s your lenses. Fortunately, 1-Day ACUVUE MOIST lenses are designed ...

In this Healio Video Perspective from Hawaiian Eye 2025, Erin Powers of Johnson & Johnson Surgical Vision discusses how the Tecnis Odyssey IOL has benefited ophthalmic practices.

Community-acquired pneumonia (CAP) is a systemic disease and continues to be the leading cause of infectious mortality ...